OCWP
EDIT icon

Owl Creek Wealth Partners’s Editas Medicine EDIT Stock Holding History

Owl Creek Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73K Hold
2,385
– – ﹤0.01% 923
2026
Q1 		$5.89K Buy
+2,385
New +$5.05K ﹤0.01% 937

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Owl Creek Wealth Partners's EDIT Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Editas Medicine (EDIT) position steady in Q2 2026 at 2,385 shares worth $7.73K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Owl Creek Wealth Partners first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Owl Creek Wealth Partners held 2,385 shares of Editas Medicine worth $7.73K as of Q2 2026.
  • Owl Creek Wealth Partners left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #923 holding.
  • Owl Creek Wealth Partners first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.